LPL Financial’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
201,224
+158,909
| +376% | +$361K | ﹤0.01% | 4378 |
|
|
2025
Q1 | $26.9K | Hold |
42,315
| – | – | ﹤0.01% | 5089 |
|
|
2024
Q4 | $43.6K | Buy |
42,315
+4,000
| +10% | +$4.12K | ﹤0.01% | 4991 |
|
|
2024
Q3 | $45.2K | Buy |
38,315
+2,000
| +6% | +$2.36K | ﹤0.01% | 4904 |
|
|
2024
Q2 | $44.3K | Sell |
36,315
-56,000
| -61% | -$68.3K | ﹤0.01% | 4754 |
|
|
2024
Q1 | $201K | Sell |
92,315
-17,950
| -16% | -$39.1K | ﹤0.01% | 4434 |
|
|
2023
Q4 | $171K | Buy |
110,265
+4,873
| +5% | +$7.55K | ﹤0.01% | 4373 |
|
|
2023
Q3 | $136K | Buy |
105,392
+7,127
| +7% | +$9.19K | ﹤0.01% | 4301 |
|
|
2023
Q2 | $169K | Buy |
98,265
+39,500
| +67% | +$67.9K | ﹤0.01% | 4155 |
|
|
2023
Q1 | $88.7K | Hold |
58,765
| – | – | ﹤0.01% | 4199 |
|
|
2022
Q4 | $94K | Buy |
58,765
+3,000
| +5% | +$4.8K | ﹤0.01% | 4158 |
|
|
2022
Q3 | $81K | Buy |
55,765
+21,025
| +61% | +$30.5K | ﹤0.01% | 4121 |
|
|
2022
Q2 | $64K | Buy |
+34,740
| New | +$64K | ﹤0.01% | 4167 |
|
|
2021
Q4 | – | Sell |
-19,075
| Closed | -$97K | – | 4347 |
|
|
2021
Q3 | $97K | Sell |
19,075
-10,325
| -35% | -$52.5K | ﹤0.01% | 4123 |
|
|
2021
Q2 | $186K | Buy |
29,400
+6,500
| +28% | +$41.1K | ﹤0.01% | 3902 |
|
|
2021
Q1 | $177K | Buy |
+22,900
| New | +$177K | ﹤0.01% | 3776 |
|